M. T. Névessignsky

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

B. Lambrecht, P. Maes, G. Meyfroidt, 2020, Trials.

Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells.

P. Martiat, M. Goldman, P. Stordeur, 2010, Human immunology.

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

D. Devine, P. Gallian, I. Hung, 2021, Vox sanguinis.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

B. Lambrecht, P. Maes, G. Meyfroidt, 2020, Trials.

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations

B. Lie, S. Buus, A. Sanchez‐Mazas, 2012, International journal of immunogenetics.

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary

D. Devine, P. Gallian, I. Hung, 2021, Vox sanguinis.

Haematopoietic stem cell transplantation for severe autoimmune diseases: new perspectives.

A. Ferster, M. T. Névessignsky, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immunotherapy using dendritic cells

M. Goldman, C. Bruyns, T. Velu, 2000 .